00 K. Van Liempt Faculty of Medicine The University of Antwerp Faculty of Medicine University Hospital Antwerp.

Slides:



Advertisements
Similar presentations
The French National Alliance for Life Sciences and Health AVIESAN Prof. André Syrota Chairman and CEO of Inserm President of Aviesan STOA, Brussels, June.
Advertisements

Antwerp University of Antwerp
Orientation Information Session Dr Shaun Roman B.Biotechnology.
Develop and Utilize Human Potential 1. Qatar Research Institutes.
Combating major diseases Gender aspects in research Gender aspects in research have a particular relevance to this theme as risk factors, biological mechanisms,
16 November 2004Biomedical Imaging BMEN Biomedical Imaging of the Future Alvin T. Yeh Department of Biomedical Engineering Texas A&M University.
1 Biomedical Sciences Public and Environmental Health Regenerative Medicine Translational Research.
Bioscience/Biomedical Research at Idaho State University Christopher Daniels, Ph.D. Director, ISU Biomedical Research Institute and Professor of Pharmaceutical.
1 Institute of Epidemiology and Infectious Diseases Research Activities The L.V. Gromashevsky Institute of Epidemiology and Infectious Diseases Svetlana.
Centre for Health & Technology Maritta Perälä-Heape, PhD Director, CHT.
Center for Biologics Evaluation and Research Applying Regulatory Science to Advance Development of Innovative, Safe and Effective Biologic Products Carolyn.
Faculty of Medicine EDUCATION, RESEARCH AND INNOVATION SINCE 1666.
What Do Toxicologists Do?
Center for Biologics Evaluation and Research FDA Overview Site Visit Carolyn A. Wilson, Ph.D. Associate Director for Research.
EoI assesment and presentation NCP 24 October 2002 Confronting the major communicable diseases linked to poverty Health Directorate F3 unit: Poverty related.
 Yulia A. Strekalova, MBA  Associate Director of Research Programs  
CRICOS: 00116K Biomedical Engineer: Design products and procedures that solve medical problems. These include artificial organs, prostheses, instrumentation,
1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product.
Medical Science Dr Linda Lefievre
The South African Malaria Initiative A Case Study E Jane Morris Bridging the Gap in Global Health Innovation - from Needs to.
Institute on Aging University of Pennsylvania Alternative Funding Strategies and the Power of Fundraising John Q. Trojanowski, M.D., Ph.D. Institute on.
Improving Animal and Human Health by Accelerating Veterinary Centered Entrepreneurship.
Proposal for a European Faculty of Regenerative Medicine ScanBalt Campus Knowledge centers.
8/27/2015 | 1 Dutch Universities: Research with Focus on Top Sectors. Cooperation with Russia in Field of Life-Science & Health Sibrandes Poppema 400 years.
One Health Grand Challenge: Major Themes for Transformative*, Collaborative Research November 12, 2013 * High socioeconomic impact on state/national/global.
FORESIGHT STUDY Future Trends and Challenges in Pathogenomics JUDITH SIMON & SVEN POMPE PROGRAMME GROUP MUT.
European Health Forum Gastein, Bad Hofgastein, Austria, September 2002 Towards the Sixth Framework Programme Parallel Forum V 26 September 2002 Public.
Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health.
ENGINEERING ORIENTATION Information on Bioengineering Curriculum and Area Electives Dr. A. Saterbak Dr. K.-Y. San.
Ghent University.
1 Karolinska University Hospital. –Presentation Heikki Teriö, FoU-manager Education:Applied Physics and Electronics Linkoping University of Technology.
Johns Hopkins Technology Transfer 1 Translational Biomedical Research: Moving Discovery from Academic Centers to the Community Translational Biomedical.
Challenges and opportunities in New Zealand’s pharmaceutical scene Kevin Sheehy – Chief Executive, Medicines New Zealand Dalton Kelly – Chief Executive,
Faculty of Medicine EDUCATION, RESEARCH AND INNOVATION SINCE 1666.
Horizon 2020 The EU Framework Programme for Research and Innovation Health, Demographic Change and Wellbeing Lul Raka, NCP for Horizon 2020 – Health.
Dr. José M. Millán, PhD Deputy Director of CIBERER Universitary Hospital La Fe, Valencia, Spain Barriers and Challenges in Rare Diseases Research Centre.
Copyright, TCD, Research & Innovation Services, 2005 September 2005 O’Reilly Institute, Trinity College Dublin Research and Innovation Services.
Faculty of Medical Sciences School of Biomedical Sciences Dr Edwin Williams Director of Studies
Public Private collaborations to optimise translational research and pathways to patients: IMI Magda Chlebus, Director Science Policy Warsaw, 22 May 2015.
Where to focus? Horizon 2020 'Health, demographic change and wellbeing' Open Info Day -Horizon 2020 'Health, demographic change and wellbeing' Brussels,
Public/Private Partnerships in Neuroscience and The George & Ann Ryan Neuroscience Institute.
Polish Technology Platform for Biotechnology Partnering Meeting in Birini, Presented by Zygmunt Krasiński National Contact Point for Research.
Georgia Institute of Technology. Georgia Tech is an innovative intellectual environment with more than 900 full-time instructional faculty and more than.
WP3 Strategic analysis of the future perspectives for cooperation and coordination Summary of the expert workshop on the European Research Agenda (WP 3)
Maastricht University Prof. dr. M. Paul, President.
Precision Medicine A New Initiative. The Concept of Precision Medicine (PM) The prevention and treatment strategies that take individual variability into.
“Human – Global – High Performance” University Presentation Tempus Meeting Moscow, May 2010 B. Huenges, A. Burger & T. Schäfer RUHR-UNIVERSITY BOCHUM CENTRE.
JoinEU-See Penta Promotional Tour. Antwerp, metropolis by the water.
Introduction to Healthcare and Public Health in the US Delivering Healthcare (Part 2) Lecture d This material (Comp1_Unit3d) was developed by Oregon Health.
EURORDIS Eurordis Position on Research Priorities for Rare Diseases.
1. Overview 1) About CMU 2) Academic programs 3) Emphases of education 4) Globalization 5) Recent achievements 6) Future campus 2.
FACULTY of ARTS and SCIENCES HARVARD BUSINESS SCHOOL GRADUATE SCHOOL OF DESIGN HARVARD DIVINITY SCHOOL Center for the Study of World Religions Summer.
GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.
Wellcome Trust / Glaxo Smith Kline Translational Medicine Training Programme at Imperial College Dr Waljit Dhillo.
Medical and Health research in Norway – in brief Director Mari K. Nes 22 June 2006.
The University of Colorado BioFrontiers
Research on Antimicrobial Resistance
Translational biomedical in vivo imaging
Guidance notes These slides are intended to support staff who are making presentations about the University and have been designed to complement the University’s.
Science for Life Laboratory
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
October 2017.
Brain Extracellular Matrix in Health and Disease
Work Programme The social challenge “Health, Demographic Change and Wellbeing” Maia Okujava NCP for Health, Demographic Change and weii-being,
Nicholas P. Ambulos, PhD Director, CIBR October 24, 2017
Strategy and Policy Cohesion: “The One Health Agenda: will it deliver”
Genetic mechanisms of schizophrenia – presentation of ERA-NET NEURON project SYNSCHIZ - Budisteanu Magdalena, Papuc Sorina-Mihaela, Sorin Riga, Dan Riga,
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Cv The Göttingen Campus A STRONG ALLIANCE.
Presentation transcript:

00 K. Van Liempt Faculty of Medicine The University of Antwerp Faculty of Medicine University Hospital Antwerp

11 The Antwerp Region people in the City of Antwerp Most important economic region in Flanders Strong economic assets: -Port of Antwerp 2nd largest in Europe; 4th world-wide -Largest cluster of petrochemical industry in the world -Diamond trade -Logistics

22 The University of Antwerp Founded in 2003 upon the merger of three independent University Institutions Roots dating back to 1852 UIA RUCAUFSIA

33 The University of Antwerp in Flanders

44 The University of Antwerp in the World University Rankings -QS World University ranking : 179 worldwide -ARWU (“Shanghai”) : worldwide Consistently in the top 250 worldwide

55 Facts and Figures Main partner in the Antwerp University Association -1 university (UA) -4 university colleges students in total 400 FTE UA-faculty staff 1200 UA-research staff 1100 UA-PhD students Around 3500 scientific works published/year articles in Web of Science/year

66 Organisational Structure Natural Sciences Sciences Humanities and Social Sciences Applied Economics Arts and Philosophy Law Political and Social Sciences Political and Social Sciences Pharmaceutical, Biomedical and Veterinary Sciences Medicine Life Sciences 7 Faculties

77 Front Line Research Domains Urban History and Contemporary Urban Policy Urban History and Contemporary Urban Policy Social Economic Policy and Organisation Ecology and Sustainable Development Materials Characterisation Drug Discovery and Development Infectious Diseases Neurosciences Imaging Harbour, Transport and Logistics

88 Front Line Research Domains Urban History and Contemporary Urban Policy Urban History and Contemporary Urban Policy Social Economic Policy and Organisation Ecology and Sustainable Development Materials Characterisation Drug Discovery and Development Infectious Diseases Neurosciences Imaging Harbour, Transport and Logistics

99 Imaging EGAMI: Expert Group Antwerp Molecular Imaging -Network of research labs Biomedical Microscopic Imaging Bioimaging Lab Molecular Imaging Center Antwerp (MICA) MicroCT Lab Vision Lab -Links with Antwerp University Hospital (UZA) Radiology Nuclear Medicine

10 Imaging Molecular and Cellular Imaging Small Animal Imaging Clinical Imaging Light Microscopy (Scanning) Electron Microscopy Fluorescence Microscopy μCT μMRI μPET In Vivo Biolumi- nescence and Fluorescence Camera CT MRI PET/SPECT Image Processing Confocal Microscopy Confocal Live Cell Imaging Electrophysiology Advanced Immuno- histochemistry Image Processing 10

11 Imaging

12 Molecular Imaging Center Antwerp (MICA) -Partnership between UA – UZA – Janssen Pharmaceutica Cyclotron + μPET/CT: micro-radiotherapy (320 keV), autoradiography, direct access to FDG, FLT, FET and possibility to produce research tracers, kinetic modeling, multimodal image registration -Fully operational spring 2011 Imaging - Highlight

13 Front Line Research Domains Urban History and Contemporary Urban Policy Urban History and Contemporary Urban Policy Social Economic Policy and Organisation Ecology and Sustainable Development Materials Characterisation Drug Discovery and Development Infectious Diseases Neurosciences Imaging Harbour, Transport and Logistics

14 Neurosciences Neuronal Degeneration Neuronal Plasticity Neuronal Repair/ Replacement Cognition and Behaviour Stem Cells Neuronal Tissue Engineering Neurogenetics Rodent Models Neurobiology Neuro- pathology Biobank/ Biomarkers Psychiatric Disorders/ Dementia Song Birds Nano- technology 14

15 Neurosciences in vivo < cellcelltissueorganism ex vivo / in vitro

16 Neurosciences - Highlight VIB Department of Molecular Genetics (VIB8) (Director: Prof. Dr. Christine Van Broeckhoven) -Genetic analysis of complex neurological and neuropsychiatric diseases To identify novel molecular mechanisms for disease causation and effective drug treatment for these diseases -4 research groups Neurodegenerative Brain Diseases Peripheral Neuropathies Neurogenetics Applied Molecular Genomics -2 centralized service facilities Diagnostic Service Facility Genetic Service Facility

17 Front Line Research Domains Urban History and Contemporary Urban Policy Urban History and Contemporary Urban Policy Social Economic Policy and Organisation Ecology and Sustainable Development Materials Characterisation Drug Discovery and Development Infectious Diseases Neurosciences Imaging Harbour, Transport and Logistics

18 Infectious Diseases Multidisciplinary research on infectious diseases and vaccines -Focused on microbiology and immunology, with contributions of other disciplines Epidemiology Statistics/Mathematical modeling Sociology Economics 18

19 Infectious Diseases Basic Research Preclinical Research Clinical Research Immune System Disease Mechanisms Antibiotic Resistance Biomarkers Vaccines Injection Devices Prevention Diagnostic Tests Vaccines Epidemiology

20 Infectious Diseases - Highlights Antibiotic use and resistance -European Surveillance of Antimicrobial Consumption (ESAC) European project coordinated by Prof. Dr. Herman Goossens of the UA -Funded by the European Centre for Disease Prevention and Control (ECDC) -34 participating countries Study of the use of antibiotics, antivirals and antimycotics and occurrence of resistance A vaccine against leukemia? -Wilms’ tumor 1 antigen-targeted dendritic cell vaccination against acute myeloid leukemia Van Tendeloo et al., PNAS, 2010

21 Front Line Research Domains Urban History and Contemporary Urban Policy Urban History and Contemporary Urban Policy Social Economic Policy and Organisation Ecology and Sustainable Development Materials Characterisation Drug Discovery and Development Infectious Diseases Neurosciences Imaging Harbour, Transport and Logistics

22 Biomarkers Toxicity Imaging Drug Discovery and Development Target Discovery Drug Discovery Preclinical Drug Development End point: Clinical Trials Disease Pathology Disease Mechanism Animal Models In vitro Screens Medicinal Chemistry Small Molecules Medicinal Plants 22

23 Drug Discovery and Development 23 Major Focus of Disease Areas: -Bone disease Osteoporosis -Cancer -Cardiovascular disease Atherosclerosis -Infectious disease Bacterial, fungal and parasitic infections -Kidney disease -Metabolic disease Diabetes

24 Drug Discovery and Development - Highlight 24 Antwerp Drug Discovery Network -Integrated Platform for early drug discovery from hit to lead optimisation -Protease Inhibitors Urokinase Plasminogen Activator (uPA) inhibitors in Oncology Molecular Probes as drug discovery tools -Infectious Diseases In vitro screening panels for antifungals and drugs against tropical diseases Reference Center World Health Organization (WHO)

25 Faculty of Medicine Overview number of students -Medecine BA-MA750 -Nursing MA194 -Specialisation250 -Doctoral School210 -Physiotherapy520 -Total

26 Faculty of Medicine Features of medical education -BA / MA structure -Competence driven and student oriented teaching -Integration of CANMEDS roles in the curriculum aimed at transforming students into medical experts -English semester, Spring, 4th year

27 University Hospital Antwerp Features of University Hospital -600 beds consultations and technical activities -300 MIO € yearly budget -Legally independent from University, but connected with several links, especially with the faculty of medicine -Close collaboration with regional hospitals